Wade G W & Inc. Invests $308,000 in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Share on StockTwits

Wade G W & Inc. purchased a new stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 2,275 shares of the financial services provider’s stock, valued at approximately $308,000.

Other institutional investors also recently added to or reduced their stakes in the company. Gryphon Financial Partners LLC acquired a new stake in iShares Nasdaq Biotechnology ETF in the 2nd quarter valued at $102,000. CWM LLC grew its stake in iShares Nasdaq Biotechnology ETF by 61.0% in the 2nd quarter. CWM LLC now owns 10,499 shares of the financial services provider’s stock valued at $1,435,000 after acquiring an additional 3,977 shares during the period. Morgan Stanley grew its stake in iShares Nasdaq Biotechnology ETF by 6.2% in the 1st quarter. Morgan Stanley now owns 5,597,848 shares of the financial services provider’s stock valued at $603,112,000 after acquiring an additional 327,597 shares during the period. Ingalls & Snyder LLC grew its stake in iShares Nasdaq Biotechnology ETF by 5.4% in the 2nd quarter. Ingalls & Snyder LLC now owns 5,500 shares of the financial services provider’s stock valued at $752,000 after acquiring an additional 283 shares during the period. Finally, Cullen Frost Bankers Inc. acquired a new stake in iShares Nasdaq Biotechnology ETF in the 2nd quarter valued at $41,000. 82.54% of the stock is currently owned by hedge funds and other institutional investors.

Shares of IBB stock opened at $141.08 on Tuesday. The stock’s fifty day moving average is $137.39 and its two-hundred day moving average is $134.77. iShares Nasdaq Biotechnology ETF has a fifty-two week low of $92.15 and a fifty-two week high of $146.53.

Separately, ValuEngine lowered iShares Nasdaq Biotechnology ETF from a “hold” rating to a “sell” rating in a report on Monday.

About iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Recommended Story: What is a growth and income fund?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply